canthin-6-one has been researched along with nigakinone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Higai, K; Koike, K; Li, W; Sasaki, T | 1 |
| Dai, W; Feng, F; He, J; Liu, W; Qu, W; Xu, J; Ye, F | 1 |
2 other study(ies) available for canthin-6-one and nigakinone
| Article | Year |
|---|---|
Canthinone alkaloids are novel protein tyrosine phosphatase 1B inhibitors.
Topics: Biological Products; Carbolines; Dose-Response Relationship, Drug; Enzyme Inhibitors; Hep G2 Cells; Humans; Indole Alkaloids; Molecular Docking Simulation; Molecular Structure; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Structure-Activity Relationship | 2015 |
Design, synthesis and
Topics: Antineoplastic Agents; Apoptosis; Carbolines; Cell Line, Tumor; Cell Proliferation; Drug Design; Drug Screening Assays, Antitumor; Hep G2 Cells; Humans; Indole Alkaloids; Indoles; Naphthyridines; Picrasma; Structure-Activity Relationship; Transcription Factor RelA | 2020 |